Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger, Makoto Tahara, Lori J. Wirth et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

Cosimo Durante, Nadia Haddy, E. Baudin et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 1.7K citations

Medicine, Oncology, Surgery +17

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis

Salvatore Vaccarella, Silvia Franceschi, Freddie Bray et al. · New England Journal of Medicine · 2016 · 1.1K citations

Medicine, Endocrinology, Oncology +11

Rare cancers are not so rare: The rare cancer burden in Europe

Gemma Gatta, Jan Maarten van der Zwan, Paolo G. Casali et al. · European Journal of Cancer · 2011 · 785 citations

Medicine, Oncology, Cancer Epidemiology +13

E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition

Junji Matsui, Yuji Yamamoto, Yasuhiro Funahashi et al. · International Journal of Cancer · 2007 · 547 citations

Medicine, Oncology, Pharmacology +17